Lectins as Antiviral
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Viral Immunology, Vaccines, and Antivirals".
Deadline for manuscript submissions: closed (31 August 2016) | Viewed by 45863
Special Issue Editor
Interests: natural products, protein chemistry, antiviral proteins, biochemistry, anti-cancer and anti-viral high-throughput screening, drug discovery
Special Issue Information
Dear Colleagues,
Increasingly over the past decade, lectins such as cyanovirin-N, scytovirin and griffithsin have been reported to display antiviral activity against numerous enveloped viruses. Lectins are carbohydrate-binding proteins found in diverse phyla throughout nature. Research into the discovery, the spectrum of antiviral activity, the specific mechanism by which lectins bind their target oligosaccharides on envelope glycoproteins, the structural basis of lectin carbohydrate specificity, the mechanism of lectin antiviral activity and its dependence on both affinity and avidity and the avenues by which viruses can become resistant to lectins, have been pursued by numerous research groups. In addition, the in vivo efficacy of lectins for antiviral therapy and prophylaxis is also an area of continuing research including all aspects of their toxicity, immunogenicity and their large-scale production for clinical utility. The goal of this Special issue is to highlight recent advances in the understanding of lectin antiviral activity and provide updates on the latest research results in this very active area of research.
Dr. Barry R. O'Keefe
Guest Editor
Keywords
- lectin
- natural products
- antiviral
- HIV
- envelope glycoprotein
- Ebola
- HCV
- coronavirus
- gp120
- SARS CoV spike glycoprotein
- carbohydrate
- glycan
- protein-carbohydrate interactions
- oligosaccharide